Strata Skin Sciences Reports Mixed Q2 Financials and Device Installations
Company Announcements

Strata Skin Sciences Reports Mixed Q2 Financials and Device Installations

Strata Skin Sciences (SSKN) has provided an update.

STRATA Skin Sciences, Inc. revealed preliminary financial figures for Q2 2024, with revenues expected between $8.0 million to $8.4 million, despite a slight decrease in its XTRAC® device installations. In contrast, installations of TheraClear®X devices showed growth, and the company ended the quarter with $6.8 million in cash and equivalents. The report also contains forward-looking statements, advising investors of potential risks and urging them to review further disclosures for a more informed perspective.

For an in-depth examination of SSKN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskStrata Skin Sciences Wins Legal Battle Over Claims
TheFlyStrata Skin announces favorable court order in complaint against LaserOptek
Brian AndersonSSKN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App